Literature DB >> 12364685

Insight into illness and attitudes toward medications among inpatients with schizophrenia.

Martha Sajatovic1, Debra S Rosch, Harry J Sivec, Dilara Sultana, Douglas A Smith, Samer Alamir, Peter Buckley, C Raymond Bingham.   

Abstract

This study assessed symptoms, severity of illness functional level, insight into illness, and attitudes toward medication in a sample of psychiatric patients who were newly admitted to a state hospital. The patients were evaluated before and after treatment with atypical, conventional, or mixed (atypical plus conventional) antipsychotic medication regimens with the Brief Psychiatric Rating Scale (BPRS), the Clinical Global Impression, the Global Assessment of Functioning, the Scale to Assess Unawareness of Mental Disorder, and the Drug Attitude Inventory. Overall, the patients showed significant improvement in symptoms, severity of illness, functional level, and insight into their illness during the course of hospitalization. Their attitudes toward medications changed minimally during treatment. Only the patients who were treated with conventional antipsychotics showed significant improvement in their attitudes toward medication. However, the change was not large enough to differentiate the conventional antipsychotic treatment group from the other treatment groups.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12364685     DOI: 10.1176/appi.ps.53.10.1319

Source DB:  PubMed          Journal:  Psychiatr Serv        ISSN: 1075-2730            Impact factor:   3.084


  17 in total

Review 1.  Determinants of functioning and well-being among individuals with schizophrenia: an integrated model.

Authors:  P T Yanos; R H Moos
Journal:  Clin Psychol Rev       Date:  2006-02-09

Review 2.  Lack of insight in schizophrenia: impact on treatment adherence.

Authors:  Peter F Buckley; Donna A Wirshing; Prameet Bhushan; Joseph M Pierre; Seth A Resnick; William C Wirshing
Journal:  CNS Drugs       Date:  2007       Impact factor: 5.749

3.  Correlates of Negative Attitudes towards Medication in People with Schizophrenia.

Authors:  Lucie Kondrátová; Daniel König; Karolína Mladá; Petr Winkler
Journal:  Psychiatr Q       Date:  2019-03

4.  Description of study population and analysis of factors influencing adherence in the observational Italian study "Evaluation of Pharmacotherapy Adherence in Bipolar Disorder" (EPHAR).

Authors:  Alessandra Barraco; Andrea Rossi; Giuseppe Nicolò
Journal:  CNS Neurosci Ther       Date:  2010-12-28       Impact factor: 5.243

5.  Depression, suicidal behavior and insight in adolescents with schizophrenia.

Authors:  Osnat Schwartz-Stav; Alan Apter; Gil Zalsman
Journal:  Eur Child Adolesc Psychiatry       Date:  2006-04-07       Impact factor: 4.785

6.  Attitudes toward psychiatric drug treatment: the experience of being treated.

Authors:  Carlos De Las Cuevas; Emilio J Sanz
Journal:  Eur J Clin Pharmacol       Date:  2007-08-16       Impact factor: 2.953

7.  Denial and acceptance coping styles and medication adherence in schizophrenia.

Authors:  Stephanie Aldebot; Amy G Weisman de Mamani
Journal:  J Nerv Ment Dis       Date:  2009-08       Impact factor: 2.254

8.  Symptom severity, self-reported adherence, and electronic pill monitoring in poorly adherent patients with bipolar disorder.

Authors:  Martha Sajatovic; Jennifer B Levin; Johnny Sams; Kristin A Cassidy; Kouri Akagi; Michelle E Aebi; Luis F Ramirez; Steven A Safren; Curtis Tatsuoka
Journal:  Bipolar Disord       Date:  2015-09       Impact factor: 6.744

Review 9.  Systematic review reveals heterogeneity in the use of the Scale to Assess Unawareness of Mental Disorder (SUMD).

Authors:  Rémy Dumas; Karine Baumstarck; Pierre Michel; Christophe Lançon; Pascal Auquier; Laurent Boyer
Journal:  Curr Psychiatry Rep       Date:  2013-06       Impact factor: 5.285

10.  Attitudes toward medication and the clinical variables in schizophrenia: Structural equation models.

Authors:  Alessandro Rossi; Roberta Pacifico; Paolo Stratta
Journal:  Patient Prefer Adherence       Date:  2009-11-03       Impact factor: 2.711

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.